Northeastern’s Dr. Alexandros Makriyannis and team reveal structure of the receptor in the brain that leads to the high associated with THC—the psychoactive ingredient in marijuana.
Discover how Biotech co-op coordinator Vanecia Harrison-Sanders helps students discover their passion through experiential opportunities.
Sleeping sickness is an insect-borne, parasitic disease found in sub-Saharan Africa. The disease is transmitted by the tsetse fly, which are large flies (similar to a horsefly) that live off of vertebrate animal blood, including humans.
To advance Northeastern’s standing as a go-to institution for academic researchers interested in drug discovery is the vision of Dr. Diomedes Logothetis, the new chair of the Department of Pharmaceutical Sciences.
New research led by Northeastern University suggests that Alzheimer’s disease may not progress like falling dominoes, as conventional wisdom holds, with one molecular event sparking the formation of plaques throughout the brain.
Kenneth Henderson can point precisely to the moment when his career spun in an exciting new direction: a five-month industry placement at Merck in London.
A team led by University Distinguished Professor of Biology Kim Lewis received a five-year, $9 million grant from the National Institute of Health’s National Institute of Allergy and Infectious Diseases to launch a novel platform for developing antibiotics that kill pathogens without encountering resistance.
Dr. Jared Auclair comes to the position having been a significant contributor to the university’s educational mission teaching Protein Mass Spectrometry and establishing and operating Northeastern’s Biopharmaceutical Analysis Training Laboratory in Burlington, MA
Now in its thirteenth year, Northeastern’s biotechnology program incorporates key concepts in business with a solid science curriculum.
Drs. Slava Epstein and Kim Lewis’s journey towards the ultimate cure is described in The New Yorker Annals of Science, June 20, 2016.